Table 3. In Vitro Potency Data for Compounds 42–52.
Compd | R1R2N | TAK1 IC50a |
---|---|---|
42 | 1-azetidinyl | 2.6 |
43 | 1-piperidinyl | 1.2 |
44 | 1-azepinyl | 2.9 |
45 | 1-(2-methylpyrrolidinyl) | 5.7 |
46 | 1-(3-methylpyrrolidinyl) | 0.9 |
47 | 1-(3-fluoropyrrolidinyl) | 1.2 |
48 | 1-(3-phenylpyrrolidinyl) | 2.3 |
49 | 1-(3-(OMe)-pyrrolidinyl) | >10 |
50 | 1-(3-(N-Ac)-pyrrolidinyl) | >10 |
51 | 1-isoindolinyl | 0.3 |
52 | 1-octahydro-1H-isoindolinyl | 3.4 |
Biochemical Lanthascreen assay with TAK1–TAB1 fusion protein in the presence of 10 μM ATP, mean IC50 values in μM, n = 2.